KIF2A decreases IL-33 production and attenuates allergic asthmatic inflammation
- Allergy Asthma Clin Immunol. 2022 Jun 19;18(1):55. doi: 10.1186/s13223-022-00697-9.
- 1. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- 2. Department of Respiratory Medicine, Shenzhen Children's Hospital, Shenzhen, China.
- 3. Jiangsu Province Engineering Research Center of Antibody Drug, NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, China. [email protected].
- 4. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. [email protected].
- # Contributed equally.
Background: The microtubule-dependent molecular motor protein Kinesin Family Member 2A (KIF2A) is down-regulated in asthmatic human airway epithelium. However, little is known about the roles of KIF2A as well as the possible underlying mechanisms in asthma.
Methods: House dust Mite (HDM) extract was administered to establish a murine model of asthma. The expression of KIF2A, IL-33 and the Autophagy pathways were detected. The plasmid pCMV-KIF2A was used to overexpress KIF2A in the airway epithelial cells in vitro and in vivo. IL-4, IL-5, IL-33 and Other cytokines in bronchoalveolar lavage fluid (BALF) and lung tissues homogenates were measured.
Results: In response to the challenge of house dust Mite (HDM) in vitro and in vivo, airway epithelial cells displayed decreased production of KIF2A. Meanwhile, Autophagy and IL-33 were increased in HMD-treated epithelial cells. Mechanistically, KIF2A decreased Autophagy via suppressing mTORC1 pathway in HDM-treated epithelial cells, which contributed to the reduced production of IL-33. Moreover, in vivo KIF2A transfection reduced IL-33 and Autophagy in the lung, leading to the attenuation of allergic asthma.
Conclusion: KIF2A suppressed mTORC1-mediated Autophagy and decreased the production of epithelial-derived cytokine IL-33 in allergic airway inflammation. These data indicate that KIF2A may be a novel target in allergic asthma.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-